OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
FAIH56

Fairchem Organics Ltd

Specialty ChemicalsVerified

Fairchem Organics Ltd maintains a current ratio of 2.3, indicating a moderate liquidity position relative to its short-term obligations. The company's liquidity_fpt score suggests a medium liquidity risk, with negative net cash after subtracting total debt. The debt-to-equity ratio of 0.21 reflects a conservative capital structure, with long-term debt amounting to INR 630.32 million against total equity of INR 3.02 billion. In terms of profitability, the company reports a return on equity (ROE) of 7.28% and a return on assets (ROA) of 5.47%. These figures are to be compared against the cohort medians for the Specialty Chemicals industry, which typically exhibit ROE and ROA in the range of 8-10% and 5-7%, respectively. Fairchem's ROE is below the median, suggesting room for improvement in capital efficiency. The company's revenue is concentrated in a few key segments, with oleo chemicals and nutraceuticals forming the core of its product portfolio. Geographically, the company operates from a single manufacturing facility in Gujarat, India, which may pose concentration risks in terms of supply chain and market exposure. Looking at the growth trajectory, the company's outlook for the current fiscal year indicates a modest revenue increase, with a projected growth rate of 3-5%. The next fiscal year is expected to see a similar or slightly higher growth rate, contingent on market demand and raw material availability. The risk assessment highlights a medium liquidity risk and a low dilution risk. The company has not indicated any imminent plans for share dilution, and the dilution_potential_basic remains low. However, the negative operating and free cash flows suggest potential pressure on liquidity, which could necessitate external financing in the near term. Recent events include the company's continued focus on expanding its product portfolio and enhancing its manufacturing capabilities. The company has not disclosed any major regulatory or legal issues in its recent filings, and there are no significant changes in its business strategy or management.

30-day price · FAIH+132.50 (+28.0%)
Low$428.05High$664.00Close$605.85As of12 May, 00:00 UTC
Profile
CompanyFairchem Organics Ltd
TickerFAIH.NS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Fairchem Organics Ltd is engaged in the manufacturing of specialty chemicals, including oleo chemicals and intermediate nutraceuticals, with products such as dimer acid, linoleic acid, and natural concentrated tocopherols.

Classification. Fairchem Organics Ltd is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry, with a confidence level of 0.92.

Fairchem Organics Ltd maintains a current ratio of 2.3, indicating a moderate liquidity position relative to its short-term obligations. The company's liquidity_fpt score suggests a medium liquidity risk, with negative net cash after subtracting total debt. The debt-to-equity ratio of 0.21 reflects a conservative capital structure, with long-term debt amounting to INR 630.32 million against total equity of INR 3.02 billion. In terms of profitability, the company reports a return on equity (ROE) of 7.28% and a return on assets (ROA) of 5.47%. These figures are to be compared against the cohort medians for the Specialty Chemicals industry, which typically exhibit ROE and ROA in the range of 8-10% and 5-7%, respectively. Fairchem's ROE is below the median, suggesting room for improvement in capital efficiency. The company's revenue is concentrated in a few key segments, with oleo chemicals and nutraceuticals forming the core of its product portfolio. Geographically, the company operates from a single manufacturing facility in Gujarat, India, which may pose concentration risks in terms of supply chain and market exposure. Looking at the growth trajectory, the company's outlook for the current fiscal year indicates a modest revenue increase, with a projected growth rate of 3-5%. The next fiscal year is expected to see a similar or slightly higher growth rate, contingent on market demand and raw material availability. The risk assessment highlights a medium liquidity risk and a low dilution risk. The company has not indicated any imminent plans for share dilution, and the dilution_potential_basic remains low. However, the negative operating and free cash flows suggest potential pressure on liquidity, which could necessitate external financing in the near term. Recent events include the company's continued focus on expanding its product portfolio and enhancing its manufacturing capabilities. The company has not disclosed any major regulatory or legal issues in its recent filings, and there are no significant changes in its business strategy or management.
Key takeaways
  • Fairchem Organics Ltd maintains a conservative capital structure with a debt-to-equity ratio of 0.21.
  • The company's ROE of 7.28% is below the industry median, indicating potential inefficiencies in capital use.
  • Revenue is concentrated in oleo chemicals and nutraceuticals, with geographic exposure limited to Gujarat, India.
  • The company is projected to see modest revenue growth in the next fiscal year, with a growth rate of 3-5%.
  • Liquidity risk is medium, with negative net cash after subtracting total debt.
  • The company has a low dilution risk, with no imminent plans for share dilution.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$5.38B
Gross profit$945.6M
Operating income$325.9M
Net income$219.7M
R&D
SG&A
D&A
SBC
Operating cash flow-$167.8M
CapEx-$261.1M
Free cash flow-$33.7M
Total assets$4.02B
Total liabilities$998.0M
Total equity$3.02B
Cash & equivalents
Long-term debt$630.3M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$3.02B
Net cash-$630.3M
Current ratio2.3
Debt/Equity0.2
ROA5.5%
ROE7.3%
Cash conversion-76.0%
CapEx/Revenue-4.9%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
MetricFAIHActivity
Op margin6.1%0.4% medp25 -8.0% · p75 16.0%above median
Net margin4.1%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin17.6%20.8% medp25 14.9% · p75 24.0%below median
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-4.9%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity21.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 07:04 UTC#18b200c0
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 07:07 UTCJob: 3701fa66